Log In
Print this Print this

brincidofovir (CMX001)

  Manage Alerts
Collapse Summary General Information
Company Chimerix Inc.
DescriptionOral lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the antiviral agent cidofovir diphosphate
Molecular Target
Mechanism of ActionDNA polymerase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today